Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Eclinicalmedicine|December 24, 2024
When to stop immunotherapy for advanced melanoma: the emulated target trialsMathilde Amiot, Laurent Mortier, Stéphane Dalle, et al.
The British Journal of Dermatology|November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingKarine Billard, Laurent Mortier, Olivier Dereure, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Prognostic classification of skin adnexal carcinomas: Results from a prospective study of 980 patients in the French CARADERM networkRobin Zagala, Stephane Dalle, Brigitte Balme, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2025
Brain metastases from Merkel cell carcinoma: A nationwide retrospective studyRaphaëlle Caillot, Astrid Blom, Céleste Lebbé, et al.
Cancer Cell|April 25, 2025
Stromal lipid species dictate melanoma metastasis and tropismShilpa Gurung, Timothy Budden, Karthik Mallela, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumorsFlorentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
The Oncologist|December 15, 2025
Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre studyAndréa Clément de Givry, Pauline Manchon, Marianne Veyri, et al.
Journal of Oncology|January 12, 2019
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaClaire Mignard, Aurélie Deschamps Huvier, André Gillibert, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2023
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, et al.
Pageof 7